​

Agenus (AGEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AGEN Stock Forecast

Agenus (AGEN) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a 236.54% increase from the last price of $2.08.

- $4 $8 $12 $16 $20 High: $7 Avg: $7 Low: $7 Last Closed Price: $2.08

AGEN Stock Rating

Agenus stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (63.64%), 4 Hold (36.36%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 4 7 Strong Sell Sell Hold Buy Strong Buy

AGEN Price Target Upside V Benchmarks

TypeNameUpside
StockAgenus236.54%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$10.20
Last Closing Price$2.08$2.08$2.08
Upside/Downside--390.38%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-14--5
Mar, 25-14--5
Feb, 25-14--5
Jan, 25-14--5
Dec, 24-14--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 29, 2024Emily BodnarH.C. Wainwright$7.00$3.5796.08%236.54%
Jul 19, 2024Biren AminJefferies$7.00$5.9916.86%236.54%
Jul 19, 2024Colleen KusyRobert W. Baird$8.00$7.309.59%284.62%
Jul 18, 2024Emily BodnarH.C. Wainwright$9.00$7.9812.78%332.69%
Jul 01, 2024Emily BodnarH.C. Wainwright$20.00$8.38138.66%861.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 29, 2024H.C. WainwrightNeutralNeutralhold
Aug 14, 2024B. RileyBuyBuyhold
Jul 19, 2024JefferiesHolddowngrade
Jul 18, 2024William BlairMarket Performdowngrade
Jul 18, 2024H.C. WainwrightBuyNeutraldowngrade
Jul 01, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-35 $-28 $-21 $-14 $-7 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.84$-8.27$-19.27$-13.75$-10.57----
Avg Forecast$-21.07$-0.74$-14.85$-12.50$-12.02$-7.19$-4.77$-5.89$-4.45
High Forecast$-14.96$-0.52$-9.73$-10.12$-9.75$-4.50$-1.96$-2.60$-2.45
Low Forecast$-34.79$-1.22$-24.02$-14.88$-14.27$-9.66$-7.85$-7.81$-7.74
Surprise %32.13%1017.57%29.76%10.00%-12.06%----

Revenue Forecast

$50M $140M $230M $320M $410M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$88.17M$295.67M$98.02M$156.31M$103.46M----
Avg Forecast$74.60M$313.14M$82.52M$118.94M$106.42M$134.11M$120.49M$125.00M$267.45M
High Forecast$111.98M$470.05M$121.71M$137.79M$116.87M$187.22M$122.54M$196.07M$419.51M
Low Forecast$57.96M$243.28M$60.63M$92.32M$96.09M$78.32M$118.44M$81.86M$175.14M
Surprise %18.19%-5.58%18.79%31.42%-2.78%----

Net Income Forecast

$-650M $-520M $-390M $-260M $-130M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-240.13M$-94.70M$-271.51M$-245.76M$-227.21M----
Avg Forecast$-376.95M$-13.17M$-47.87M$-245.97M$-227.86M$-126.76M$-87.84M$-93.15M$-79.63M
High Forecast$-267.63M$-9.35M$-1.57M$-65.00M$-174.52M$-80.59M$-35.14M$-46.49M$-43.90M
Low Forecast$-622.51M$-21.75M$-94.17M$-426.95M$-255.42M$-172.93M$-140.54M$-139.81M$-138.49M
Surprise %-36.30%619.03%467.23%-0.09%-0.28%----

AGEN Forecast FAQ

Is Agenus stock a buy?

Agenus stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Agenus is a favorable investment for most analysts.

What is Agenus's price target?

Agenus's price target, set by 11 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential 236.54% change from the previous closing price of $2.08.

How does Agenus stock forecast compare to its benchmarks?

Agenus's stock forecast shows a 236.54% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Agenus over the past three months?

  • April 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.

What is Agenus’s EPS forecast?

Agenus's average annual EPS forecast for its fiscal year ending in December 2025 is $-7.19, marking a -31.98% decrease from the reported $-10.57 in 2024. Estimates for the following years are $-4.77 in 2026, $-5.89 in 2027, and $-4.45 in 2028.

What is Agenus’s revenue forecast?

Agenus's average annual revenue forecast for its fiscal year ending in December 2025 is $134.11M, reflecting a 29.62% increase from the reported $103.46M in 2024. The forecast for 2026 is $120.49M, followed by $125M for 2027, and $267.45M for 2028.

What is Agenus’s net income forecast?

Agenus's net income forecast for the fiscal year ending in December 2025 stands at $-127M, representing a -44.21% decrease from the reported $-227M in 2024. Projections indicate $-87.839M in 2026, $-93.151M in 2027, and $-79.63M in 2028.